John Cochran

John Cochran

Director/Board Member at AQUESTIVE THERAPEUTICS, INC.

Net worth: 390 980 $ as of 30/04/2024

58 year
Finance
Commercial Services
Health Technology

Profile

Mr. John Cochran, CPA, is an Independent Director at Aquestive Therapeutics, Inc., a Partner at Bratton Capital Management LP, an Advisor at Dunrath Capital, Inc. and a partner at Crestline Investors, Inc. He is on the Board of Directors at Crestline Canada, Inc., Aquestive Therapeutics, Inc. and Crestline Investors, Inc. Previously, Mr. Cochran spent 10 years with KPMG Peat Marwick, LLP, working with a wide array of LBO funds, private equity funds, hedge funds, investment companies, venture capital groups and broker dealers.
Mr. Cochran is a CPA and earned a BBA in Accounting from Texas Christian University in 1987.

Known holdings in public companies

CompanyDateNumber of sharesValuationValuation date
22/03/2024 99,486 ( 0.11% ) 390 980 $ 30/04/2024

John Cochran active positions

CompaniesPositionStart
AQUESTIVE THERAPEUTICS, INC. Director/Board Member 01/01/2004
Private Equity Investor -
Chief Operating Officer 01/10/1998
Chief Executive Officer 01/10/1998
Director/Board Member 27/07/2009
Chief Operating Officer -
All active positions of John Cochran

Former positions of John Cochran

CompaniesPositionEnd
KPMG Peat Marwick LLP Private Equity Investor 31/10/1998
Corporate Officer/Principal -
See the detail of John Cochran's experience

Training of John Cochran

Texas Christian University Undergraduate Degree

Experiences
Positions held

Active

Inactive

Listed companies

Private companies

See the detail of John Cochran's experience

Connections

100 +

1st degree connections

9

1st degree companies

Male

Female

Members of the board

Executives

See the personal network

Linked companies

Listed companies1
AQUESTIVE THERAPEUTICS, INC.

Health Technology

Private companies7

Finance

KPMG Peat Marwick LLP

Commercial Services

Finance

Commercial Services

Finance

Finance

Finance

See company connections
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW